| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/15/2006 | CA2589746A1 Methods for diagnosis and treatment of crohn's disease |
| 06/15/2006 | CA2588270A1 Methods and compositions for treating ocular disorders |
| 06/15/2006 | CA2587693A1 Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene |
| 06/15/2006 | CA2587519A1 Selecting patients for therapy with a her inhibitor |
| 06/15/2006 | CA2587338A1 Populations of reporter sequences and methods of their use |
| 06/15/2006 | CA2587270A1 Early detection of sepsis |
| 06/15/2006 | CA2585587A1 Methods using mitochondrial nucleic acid for determining a health status of an individual |
| 06/15/2006 | CA2581122A1 Cell measuring method |
| 06/14/2006 | EP1669902A2 Probe design methods and microarrays |
| 06/14/2006 | EP1669761A2 Method for automatically determining the endogenous thrombin potential |
| 06/14/2006 | EP1669748A1 Biomolecule detecting element and method for analyzing nucleic acid using the same |
| 06/14/2006 | EP1669464A1 Dna detection method using molecular beacon with the use of monomer fluorescence/excimer fluorescence switching of fluorescent molecule |
| 06/14/2006 | EP1669453A1 Novel nerve stem cell marker |
| 06/14/2006 | EP1669451A1 Brain tumor marker and method of diagnosing brain tumor |
| 06/14/2006 | EP1669447A1 SNPs IN 5' REGULATORY REGION OF MDR1 GENE |
| 06/14/2006 | EP1669371A2 Composition and methods for the diagnosis of tumours |
| 06/14/2006 | EP1669369A2 Nucleic acid sequence encoding the OPCA gene |
| 06/14/2006 | EP1669022A2 Sensor head for monitoring glucose for use with implantable devices |
| 06/14/2006 | EP1668373A1 Method for detecting procoagulant phospholipid |
| 06/14/2006 | EP1668372A1 Elastin peptide fingerprints and analysis methods for mmp12 related to copd |
| 06/14/2006 | EP1668367A1 Methods, compositions, and kits for detecting cryptosporidium pathogens |
| 06/14/2006 | EP1668366A2 Using liquid crystals to detect affinity microcontact printed biomolecules |
| 06/14/2006 | EP1668360A2 Multifactorial assay for cancer detection |
| 06/14/2006 | EP1668357A2 Materials and methods relating to breast cancer classification |
| 06/14/2006 | EP1668354A2 Method of diagnosing breast cancer |
| 06/14/2006 | EP1668337A2 Methods for optimizing clinical responsiveness to methotrexate therapy using metabolite profiling and pharmacogenetics |
| 06/14/2006 | EP1668164A2 Programmable molecular barcodes |
| 06/14/2006 | EP1668163A2 Method for the diagnosis/prognosis of neuroblastoma |
| 06/14/2006 | EP1668162A1 Detection of immobilized nucleic acid |
| 06/14/2006 | EP1668161A2 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 06/14/2006 | EP1668160A2 Methods, compositions, and kits for the concentration and detection of microorganisms |
| 06/14/2006 | EP1668159A2 Detection of 13q14 chromosomal alterations |
| 06/14/2006 | EP1668158A2 Rna detection and quantitation |
| 06/14/2006 | EP1668157A2 Hairpin-labeled probes and methods of use |
| 06/14/2006 | EP1668156A2 Method of diagnosing breast cancer |
| 06/14/2006 | EP1668155A2 Methods for detecting, diagnosing and treating hepatocellular carcinomas (hcc) |
| 06/14/2006 | EP1668154A2 Methods and kits useful for detecting an alteration in a locus copy number |
| 06/14/2006 | EP1668153A1 Identification of polymorphisms in the epcr gene associated with thrombotic risk |
| 06/14/2006 | EP1668152A1 Identification of an erbb2 gene expression signature in breast cancer |
| 06/14/2006 | EP1668151A2 Materials and methods relating to breast cancer diagnosis |
| 06/14/2006 | EP1668150A1 Quantification schemes for quantifying nucleic acids |
| 06/14/2006 | EP1668149A1 Diagnostic marker for ovarian cancer |
| 06/14/2006 | EP1668148A1 Nucleic acid detection assay |
| 06/14/2006 | EP1668147A2 Detection of living cells in polymers or pigments |
| 06/14/2006 | EP1668146A2 Homogeneous populations of molecules |
| 06/14/2006 | EP1668145A2 SENSE ANTIVIRAL COMPOUND AND METHOD FOR TREATING ssRNA VIRAL INFECTION |
| 06/14/2006 | EP1668120A2 Method for detecting cancer cells and monitoring cancer therapy |
| 06/14/2006 | EP1668115A2 Counting biological agents on biological growth plates |
| 06/14/2006 | EP1668114A2 Polypeptide display libraries and methods of making and using thereof |
| 06/14/2006 | EP1668111A2 Osteoarthritis biomarkers and uses thereof |
| 06/14/2006 | EP1668050A2 Attachment of molecules to surfaces |
| 06/14/2006 | EP1668037A1 Interacting polypeptide comprising a heptapeptide pattern and a cellular penetration domain |
| 06/14/2006 | EP1668028A1 Antisense compound and method for selectively killing activated t cells |
| 06/14/2006 | EP1668025A2 Seneca valley virus based compositions and methods for treating disease |
| 06/14/2006 | EP1668024A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 06/14/2006 | EP1667829A2 Image processing method and system for microfluidic devices |
| 06/14/2006 | EP1667735A2 Inhibition of inward sodium currents in cancer |
| 06/14/2006 | EP1667716A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 06/14/2006 | EP1667707A1 Methods of stimulating innate immunity using cationic peptides |
| 06/14/2006 | EP1667630A2 Methods and compositions for the prevention and treatment of genitourinary disorders, including pre-term labor and leiomyomas |
| 06/14/2006 | EP1667570A2 Assay for sars coronavirus by amplification and detection of nucleocapsid rna sequence |
| 06/14/2006 | EP1633864A4 High throughput assay of lp-pla2 activity |
| 06/14/2006 | EP1601790B1 Nucleic acid biosensors |
| 06/14/2006 | EP1532267A4 Test strip for detection of analyte and methods of use |
| 06/14/2006 | EP1495129A4 Hybrid phosphoinositide phospholipids: compositions and uses |
| 06/14/2006 | EP1471931A4 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 06/14/2006 | EP1436401A4 Stem-loop vector system |
| 06/14/2006 | EP1432831A4 Human mitochondrial dna polymorphisms, haplogroups, associations with physiological conditions, and genotyping arrays |
| 06/14/2006 | EP1393075A4 Methods of screening and using inhibitors of angiogenesis |
| 06/14/2006 | EP1328627B1 Method for generating a library of oligonucleotides comprising a controlled distribution of mutations |
| 06/14/2006 | EP1320632B1 Method for determining the age of individuals |
| 06/14/2006 | EP1309861B1 Functional protein arrays |
| 06/14/2006 | EP1309703B1 Kallikrein gene |
| 06/14/2006 | EP1266227B1 Synergistic activation of regulatory elements by rel proteins and a steroid receptor |
| 06/14/2006 | EP1266037B1 High throughput screening by measurement of intracellular calcium levels |
| 06/14/2006 | EP1242186B1 Method for processing a nucleic acid template using an integrated microfluidic disc |
| 06/14/2006 | EP1197564B1 Method of pretreatment of sample for quantitating cholesterol and method for quantitating cholesterol in specific lipoproteins by using the same |
| 06/14/2006 | EP1192283B1 Use of the combing process for the identification of dna origins of replication |
| 06/14/2006 | EP1179089B1 Method for obtaining a plant with a lasting resistance to a pathogen |
| 06/14/2006 | EP1177316B1 Polynucleotide probes for detection and quantitation of actinomycetes |
| 06/14/2006 | EP1155147B1 Methods for preserving dna integrity |
| 06/14/2006 | EP1117423B1 Immortalized human keratinocyte cell line |
| 06/14/2006 | EP1100972B1 Reversible inhibiting probes |
| 06/14/2006 | EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 06/14/2006 | EP1049798B1 Antibiotic sensitivity testing |
| 06/14/2006 | EP1045926B1 Gene family with transformation modulating activity |
| 06/14/2006 | EP1043406B1 Analysis of predisposition to an obstructive pulmonary disease based on human airway tripsin protease gene polymorphism |
| 06/14/2006 | EP0958375B1 Detection of conditions by analysis of gases or vapours |
| 06/14/2006 | EP0951567B1 Use of prostate tumor inducing gene for detection of cancer cells |
| 06/14/2006 | EP0827533B1 Enzyme and microorganism degrading rhamnogalacturonane ii |
| 06/14/2006 | EP0760867B1 Compositions and methods relating to dna mismatch repair genes |
| 06/14/2006 | EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
| 06/14/2006 | EP0639276B1 Factorial chemical libraries |
| 06/14/2006 | DE19820850B4 Verfahren zur Bestimmung von extracellulärem pH A method for the determination of pH extracellulärem |
| 06/14/2006 | DE102005008224B3 Apparatus for automatically activating microfluid device, for carrying out biochemical purifications and assays, having activator controlled on the basis of measurements of exerted force |
| 06/14/2006 | DE102004059925A1 Visualization and inhibition of intracellular protein activity comprises binding the domain for the protein molecules and oligomerizing the valences of the molecules in their active form |
| 06/14/2006 | DE102004056794A1 Protein-Biochip zur Validierung von Bindern Protein biochip for validation of binders |
| 06/14/2006 | CN2788189Y System for automatically distinguishing correction value of blood sugar test strip |
| 06/14/2006 | CN1788092A Engineering of leader peptides for the secretion of recombinant proteins in bacteria |
| 06/14/2006 | CN1788005A Novel phenoxazinone derivatives as enzyme substrates and use thereof as indicator in the detection of microorganisms with peptidase activity |